Skip to Main Content

Paper Details

A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
1
2023
CDK4, CDK6, CDKN2A/B, DHG, DMG, DMG tumors, FGFR1, FGFR1 point mutations, H3F3A, H3F3A-mutant, H3G34-mutant, H3G34-mutant DHG, H3K27, H3K27M, H3K27M-mutant, H3K27M-mutant DMG, Malignant brain tumors, NF1, PDGFRA, PIK3CA, PIK3R1, cell-cycle pathway genes, diffuse gliomas, diffuse hemispheric glioma, diffuse midline glioma, patient, patients, pediatric, pediatric and adult diffuse high-grade gliomas
Author NameAffiliation
Priscilla K BrastianosMassachusetts General Hospital Cancer Center, Harvard Medical School
Mariella G Filbin
Mariella G FilbinBroad Institute of MIT and Harvard
Sandro SantagataBrigham and Women's Hospital, Harvard Medical School
Sandro SantagataHarvard Medical School
Sandro SantagataHarvard Medical School
  • 1 - 6

Datasets

Release 1.2